Anticoagulation Therapy in the Very Old
NCT03103763 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132
Last updated 2021-08-17
Summary
This study is designed to evaluate the efficacy and safety of warfarin anticoagulation in the very old and attempt to identify risk factors which may impede safe and effective anticoagulation.
Conditions
Interventions
- DRUG
-
Warfarin
Patients on warfarin for atrial fibrillation
Sponsors & Collaborators
-
Robert Stein
lead OTHER
Principal Investigators
-
Robert W. Stein, MD · MaineHealth
Eligibility
- Min Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-20
- Primary Completion
- 2019-09-03
- Completion
- 2019-09-03
Countries
- United States
Study Locations
More Related Trials
-
Warfarin - How Good Are we at Maintaining Target Range ?
NCT01081327 ·Status: COMPLETED
-
Validation of Predictors of OAC Initiation Using EMR Data
NCT03006341 ·Status: COMPLETED
-
Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
NCT01610141 ·Status: UNKNOWN ·Phase: PHASE4
-
DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation
NCT00806624 ·Status: COMPLETED ·Phase: PHASE2
-
Clarification of Optimal Anticoagulation Through Genetics
NCT00839657 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty
NCT04878497 ·Status: UNKNOWN
-
Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients
NCT00356759 ·Status: COMPLETED ·Phase: PHASE2
-
PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care
NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study to Test the Accuracy of a Prototype Handheld PT/INR Device
NCT01349712 ·Status: UNKNOWN
-
Anti-thrombotic Monotherapy With the HeartMate 3 LVAS
NCT03704220 ·Status: UNKNOWN ·Phase: NA
-
Does Anticoagulant Control Change Following Referral Back to the Primary Care Physician?
NCT00735189 ·Status: COMPLETED ·Phase: PHASE4
-
Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
NCT03147638 ·Status: UNKNOWN ·Phase: PHASE3
-
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
NCT01305148 ·Status: SUSPENDED ·Phase: NA
-
Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS)
NCT03781258 ·Status: UNKNOWN ·Phase: NA
-
Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity
NCT02069132 ·Status: UNKNOWN
-
The Study of Warfarin Maintenance Dose in Chinese Patients
NCT01855737 ·Status: UNKNOWN
-
Predictors of Anticoagulation Control on Warfarin Therapy
NCT00905177 ·Status: COMPLETED
-
Genetic Determinants of Warfarin Anticoagulation Effect
NCT00162435 ·Status: UNKNOWN ·Phase: NA
-
Pharmacogenetics of Warfarin in Puerto Ricans.
NCT01318057 ·Status: COMPLETED
-
Comparative Effectiveness and Safety Between Warfarin and Dabigatran
NCT03254134 ·Status: COMPLETED
-
Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy
NCT00993200 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
NCT02376803 ·Status: COMPLETED ·Phase: PHASE4
-
Genotype-guided Versus Standard for Warfarin Dosing
NCT03479684 ·Status: COMPLETED ·Phase: NA
-
Direct Oral Anticoagulants and Venous Thromboembolism
NCT02833987 ·Status: COMPLETED
-
A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation
NCT00504556 ·Status: COMPLETED ·Phase: PHASE2